Literature DB >> 10068604

Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women.

C S Lachenauer1, D L Kasper, J Shimada, Y Ichiman, H Ohtsuka, M Kaku, L C Paoletti, P Ferrieri, L C Madoff.   

Abstract

Infection by group B streptococcus (GBS) is an important cause of bacterial disease in neonates, pregnant women, and nonpregnant adults. Whereas serotypes Ia, Ib, II, III, and V are most commonly associated with colonization and disease in the United States, strains of other serotypes have been isolated from patients in Japan. By use of an inhibition ELISA, the serotypes of 73 vaginal colonizing GBS strains isolated from healthy pregnant Japanese women were investigated. Twenty-six (35.6%) were type VIII, 18 (24.7%) were type VI, and the remaining 29 were distributed among more traditional serotypes. Strains were also tested by immunoblot for the presence of GBS surface proteins. Fifty-three (72.6%) of the 73 strains expressed one or more laddering GBS proteins. These data show that type VI and VIII GBS strains are common vaginal isolates in pregnant Japanese women and that one or more laddering proteins are present in most GBS strains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068604     DOI: 10.1086/314666

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  62 in total

1.  Mosaicism in the alpha-like protein genes of group B streptococci.

Authors:  C S Lachenauer; R Creti; J L Michel; L C Madoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  False-negative results in typing of group B streptococci by the standard lancefield antigen extraction method.

Authors:  H-C Slotved; S Sauer; H B Konradsen
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

4.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.

Authors:  Noriyuki Nagano; Yukiko Nagano; Fumiaki Taguchi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  ISSa4-based differentiation of Streptococcus agalactiae strains and identification of multiple target sites for ISSa4 insertions.

Authors:  Alexander Dmitriev; Adong Shen; Xuzhuang Shen; Yonghong Yang
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

6.  Emergence of invasive serotype VIII group B streptococcal infections in Denmark.

Authors:  Kim Ekelund; Hans-Christian Slotved; Hans Ulrik Nielsen; Margit S Kaltoft; Helle B Konradsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

7.  Increased sensitivity of a latex agglutination method for serotyping group B streptococcus.

Authors:  John A Elliott; Terry A Thompson; Richard R Facklam; Hans-Christian Slotved
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.

Authors:  Mioko Fujieda; Youko Aoyagi; Kousaku Matsubara; Yasuhito Takeuchi; Wakae Fujimaki; Misao Matsushita; John F Bohnsack; Shinji Takahashi
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

9.  Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

10.  Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.

Authors:  Fanrong Kong; Lotte Munch Lambertsen; Hans-Christian Slotved; Danny Ko; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.